Healthcare & Life Sciences
Cellbricks Therapeutics
Germanycellbrickstherapeutics.com
Cellbricks Therapeutics is a series b startup. 1 investor tracked. Status: possibledead.
unknownseries-b
series-b
Stage
1
Investors
About Cellbricks Therapeutics
Cellbricks Therapeutics is a company headquartered in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Cellbricks Therapeutics focuses on developing 3D-printed human tissues for pharmaceutical research and regenerative medicine.
Explore Cellbricks Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.